Trials / Conditions / Non-Small Cell Lung Cancer With EGFR Mutation
Non-Small Cell Lung Cancer With EGFR Mutation
6 registered clinical trials studyying Non-Small Cell Lung Cancer With EGFR Mutation — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase I Study of CFT8919 in Patients With Advanced NSCLC NCT06641609 | Betta Pharmaceuticals Co., Ltd. | Phase 1 |
| Recruiting | A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib NCT06668103 | Abbisko Therapeutics Co, Ltd | Phase 2 |
| Recruiting | A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCL NCT06306456 | Suzhou Genhouse Bio Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC NCT05852990 | Instituto Nacional de Cancerologia de Mexico | Phase 3 |
| Completed | Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib NCT04770688 | Shanghai Chest Hospital | Phase 1 / Phase 2 |
| Completed | Keynatinib in Treated Patients With NSCLC and Brain Metastases NCT04824079 | Medolution Ltd. | Phase 2 |